» Articles » PMID: 33102493

The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1

Overview
Specialty Cell Biology
Date 2020 Oct 26
PMID 33102493
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

First described in 1991, Yin Yang 1 (YY1) is a transcription factor that is ubiquitously expressed throughout mammalian cells. It regulates both transcriptional activation and repression, in a seemingly context-dependent manner. YY1 has a well-established role in the development of the central nervous system, where it is involved in neurogenesis and maintenance of homeostasis in the developing brain. In neurodevelopmental and neurodegenerative disease, the crucial role of YY1 in cellular processes in the central nervous system is further underscored. In this mini-review, we discuss the various mechanisms leading to the transcriptional activating and repressing roles of YY1, including its role as a traditional transcription factor, its interactions with cofactors and chromatin modifiers, the role of YY1 in the non-coding genome and 3D chromatin organization and the possible implications of the phase-separation mechanism on YY1 function. We provide examples on how these processes can be involved in normal development and how alterations can lead to various diseases.

Citing Articles

YY1 mutations disrupt corticogenesis through a cell type specific rewiring of cell-autonomous and non-cell-autonomous transcriptional programs.

Pereira M, Finazzi V, Rizzuti L, Aprile D, Aiello V, Mollica L Mol Psychiatry. 2025; .

PMID: 39987231 DOI: 10.1038/s41380-025-02929-x.


Neuronal Activity-Dependent Gene Dysregulation in iNeuronal Models of ALS/FTD Pathogenesis.

Ghaffari L, Welebob E, Boehringer A, Cyliax K, Pasinelli P, Trotti D bioRxiv. 2025; .

PMID: 39975241 PMC: 11838197. DOI: 10.1101/2025.01.27.632228.


Yin Yang 1: Function, Mechanisms, and Glia.

Rodriguez-Campuzano A, Castelan F, Hernandez-Kelly L, Felder-Schmittbuhl M, Ortega A Neurochem Res. 2025; 50(2):96.

PMID: 39904836 PMC: 11794380. DOI: 10.1007/s11064-025-04345-7.


The Role of YY1 in the Regulation of LAG-3 Expression in CD8 T Cells and Immune Evasion in Cancer: Therapeutic Implications.

Merenstein A, Obeidat L, Zaravinos A, Bonavida B Cancers (Basel). 2025; 17(1.

PMID: 39796650 PMC: 11718991. DOI: 10.3390/cancers17010019.


Denovo variants in POGZ and YY1 genes: The novel mega players for neurodevelopmental syndromes in two unrelated consanguineous families.

Ul Mudassir B, Mudassir M, Williams J, Agha Z PLoS One. 2025; 20(1):e0315597.

PMID: 39775551 PMC: 11709262. DOI: 10.1371/journal.pone.0315597.


References
1.
Beagan J, Duong M, Titus K, Zhou L, Cao Z, Ma J . YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment. Genome Res. 2017; 27(7):1139-1152. PMC: 5495066. DOI: 10.1101/gr.215160.116. View

2.
Merkenschlager M, Nora E . CTCF and Cohesin in Genome Folding and Transcriptional Gene Regulation. Annu Rev Genomics Hum Genet. 2016; 17:17-43. DOI: 10.1146/annurev-genom-083115-022339. View

3.
Liu W, Guo Q, Zhao H . Oxidative stress-elicited YY1 potentiates antioxidative response via enhancement of NRF2-driven transcriptional activity: A potential neuronal defensive mechanism against ischemia/reperfusion cerebral injury. Biomed Pharmacother. 2018; 108:698-706. DOI: 10.1016/j.biopha.2018.09.082. View

4.
Seo J, Zilber Y, Babayeva S, Liu J, Kyriakopoulos P, De Marco P . Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans. Hum Mol Genet. 2015; 24(13):3893. DOI: 10.1093/hmg/ddv131. View

5.
Nguyen N, Zhang X, Olashaw N, Seto E . Molecular cloning and functional characterization of the transcription factor YY2. J Biol Chem. 2004; 279(24):25927-34. DOI: 10.1074/jbc.M402525200. View